Funding for this research was provided by:
Helse Sør-Øst RHF (14/01152-5)
Received: 18 December 2019
Accepted: 2 March 2020
First Online: 2 April 2020
Ethics approval and consent to participate
: This trial is conducted in accordance with ethical principles according to the Declaration of Helsinki. It is further in accordance with Good Clinical Practice and all Norwegian regulatory requirements for study conduct. All participants, i.e. patients and caregivers, must provide their written informed consent before study inclusion, after being informed in oral and writing by study personnel. As caregivers are approached also after the patient’s death, a new consent form is provided.Ethical approval of the final version of this protocol (16 December 2016) was confirmed from the Regional Committee for Medical and Health Research Ethics (REC) in South East Norway (RefID: 2016/1220-PALLiON) and submitted to the other regional REC committees upon request, which is valid for all Norwegian institutions. The trial was registered in the ExternalRef removed database (No. ExternalRef removed) in March 2017.
: Not applicable.
: The authors declare that they have no competing interests.